Work

Abstract LB-162: Targeting CXCR4 for treatment of relapsed or refractory AML.

Year: 2013

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2013-lb-162

Authors: Geoffrey L. Uy, Michael P. Rettig, Kyle McFarland, John F. DiPersio

Institution: Washington University in St. Louis

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1969896463

Cites:

Cited by:

Related to: 10